These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7790404)

  • 1. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain.
    Betz AL; Yang GY; Davidson BL
    J Cereb Blood Flow Metab; 1995 Jul; 15(4):547-51. PubMed ID: 7790404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist.
    Yang GY; Liu XH; Kadoya C; Zhao YJ; Mao Y; Davidson BL; Betz AL
    J Cereb Blood Flow Metab; 1998 Aug; 18(8):840-7. PubMed ID: 9701345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Attenuation of reperfusion injury in the mouse transfected interleukin-1 receptor antagonist].
    Mao Y; Zhou L; Yang G
    Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):698-701. PubMed ID: 11798839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury.
    Yang GY; Zhao YJ; Davidson BL; Betz AL
    Brain Res; 1997 Mar; 751(2):181-8. PubMed ID: 9099804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of intercellular adhesion molecule 1 (ICAM-1) is reduced in permanent focal cerebral ischemic mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist.
    Yang GY; Mao Y; Zhou LF; Gong C; Ge HL; Betz AL
    Brain Res Mol Brain Res; 1999 Mar; 65(2):143-50. PubMed ID: 10064885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human interleukin-1 receptor antagonist in mouse lungs using a recombinant adenovirus: effects on vector-induced inflammation.
    McCoy RD; Davidson BL; Roessler BJ; Huffnagle GB; Simon RH
    Gene Ther; 1995 Sep; 2(7):437-42. PubMed ID: 7584121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain ischemia augments exo-focal transgene expression of adenovirus-mediated gene transfer to ependyma in hypertensive rats.
    Kumai Y; Ooboshi H; Kitazono T; Takada J; Ibayashi S; Fujishima M; Iida M
    Exp Neurol; 2003 Dec; 184(2):904-11. PubMed ID: 14769382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat.
    Loddick SA; Rothwell NJ
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):932-40. PubMed ID: 8784237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy.
    Nixon AJ; Haupt JL; Frisbie DD; Morisset SS; McIlwraith CW; Robbins PD; Evans CH; Ghivizzani S
    Gene Ther; 2005 Jan; 12(2):177-86. PubMed ID: 15578043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist.
    Pan RY; Chen SL; Xiao X; Liu DW; Peng HJ; Tsao YP
    Arthritis Rheum; 2000 Feb; 43(2):289-97. PubMed ID: 10693868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
    Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of intracerebral hemorrhage and thrombin-induced brain edema by overexpression of interleukin-1 receptor antagonist.
    Masada T; Hua Y; Xi G; Yang GY; Hoff JT; Keep RF
    J Neurosurg; 2001 Oct; 95(4):680-6. PubMed ID: 11596963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
    Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
    Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector.
    Roessler BJ; Hartman JW; Vallance DK; Latta JM; Janich SL; Davidson BL
    Hum Gene Ther; 1995 Mar; 6(3):307-16. PubMed ID: 7779914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat.
    Stroemer RP; Rothwell NJ
    J Cereb Blood Flow Metab; 1997 Jun; 17(6):597-604. PubMed ID: 9236716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous interleukin-1 receptor antagonist is neuroprotective.
    Loddick SA; Wong ML; Bongiorno PB; Gold PW; Licinio J; Rothwell NJ
    Biochem Biophys Res Commun; 1997 May; 234(1):211-5. PubMed ID: 9168991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral administration of Interleukin-1 Receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat.
    Relton JK; Martin D; Thompson RC; Russell DA
    Exp Neurol; 1996 Apr; 138(2):206-13. PubMed ID: 8620919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term retinal transgene expression with FIV versus adenoviral vectors.
    Loewen N; Leske DA; Cameron JD; Chen Y; Whitwam T; Simari RD; Teo WL; Fautsch MP; Poeschla EM; Holmes JM
    Mol Vis; 2004 Apr; 10():272-80. PubMed ID: 15094709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors.
    Bajocchi G; Feldman SH; Crystal RG; Mastrangeli A
    Nat Genet; 1993 Mar; 3(3):229-34. PubMed ID: 8485578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.